HANOI, VIETNAM – Media OutReach Newswire – 29 February 2024 –VinBrain, a pioneering AI HealthTech company within Vingroup conglomerate, has officially signed a commercial agreement with Global Fund to transfer Artificial Intelligence (AI) technology for Tuberculosis (TB) screening and detection as part of Vietnam’s National Tuberculosis Prevention Campaign. VinBrain is the sole entity chosen for this agreement with Global Fund in 2024. DrAid™ for TB Screening, a solution developed from VinBrain’s innovative and visionary approach to applying advanced technology, aligns with the stringent criteria of the Fund, contributing to community health and progress.
